ArticleThe Journal of biological chemistry2016

Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept.

Adam Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.